Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions. - Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; et al. (The lancet. Gastroenterology & hepatology, 2024)